Elanco Animal Health (ELAN) Cash from Operations (2017 - 2026)
Elanco Animal Health (ELAN) reported Cash from Operations of 13000000.0 for Q1 2026, up 425.0% on a YoY basis from 2476190.48 in Q1 2025, and down 87.96% sequentially from 108000000.0 in Q4 2025.
Elanco Animal Health (ELAN) Cash from Operations (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Cash from Operations data on file, last reported at 13000000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 425.0% year-over-year to 13000000.0; the trailing twelve-month figure through Mar 2026 stood at 577000000.0 (up 7.85% YoY), and the FY2025 full-year result was 560000000.0, up 3.51% from the prior year.
- Cash from Operations declined to 13000000.0 in Q1 2026, from 108000000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 312000000.0 in Q2 2022 to a low of 145000000.0 in Q1 2023.
- A 5-year average of 108058823.53 and a median of 157000000.0 in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 381.82% in 2022 and soared 1107.69% in 2023, its largest moves.
- Tracing ELAN's Cash from Operations over 5 years: stood at 13000000.0 in 2022, then soared by 1107.69% to 157000000.0 in 2023, then advanced by 12.74% to 177000000.0 in 2024, then slumped by 38.98% to 108000000.0 in 2025, then sank by 87.96% to 13000000.0 in 2026.
- Business Quant data shows ELAN's Cash from Operations at 13000000.0 in Q1 2026, 108000000.0 in Q4 2025, and 219000000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 11.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 108.00 Mn |
| Dec 31, 2025 | 108.00 Mn |
| Sep 30, 2025 | 219.00 Mn |
| Sep 30, 2025 | 219.00 Mn |
| Jun 30, 2025 | 237.00 Mn |
| Jun 30, 2025 | 237.00 Mn |
| Mar 31, 2025 | -4.00 Mn |
| Mar 31, 2025 | -4.00 Mn |
| Dec 31, 2024 | 177.00 Mn |
| Dec 31, 2024 | 177.00 Mn |
| Sep 30, 2024 | 162.00 Mn |
| Sep 30, 2024 | 162.00 Mn |
| Jun 30, 2024 | 200.00 Mn |
| Jun 30, 2024 | 200.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 157.00 Mn |
| Dec 31, 2023 | 157.00 Mn |